The at-home kit, according to the FDA, is the first of its kind to test for chlamydia, gonorrhea and trichomoniasis, three of the most common STIs with symptoms that often go unnoticed.

A sore throat is a common symptom of many conditions. However, some causes, such as swollen lymph nodes and direct injury, may only affect one side of the throat. There are many possible reasons ...

Sanofi’s chlamydia vaccine candidate was designed to protect against primary genital tract infection and reinfection by the bacterium Chlamydia trachomatis. The Food and Drug Administration (FDA) has ...

A sore throat is quite a normal symptom that many people experience from time to time. It is often linked to seasonal illnesses such as colds and flu. While this is, therefore, not usually ...

Maternal uncle says Monty had been demanding his rightful share of the family land —approximately 10 bighas, but his stepmother and step siblings were allegedly unwilling to divide the property ...

The test for chlamydia, gonorrhea, and trichomoniasis produces results in 30 minutes. Experts say the kit allows people to test themselves for STDs in the privacy of their home. The Food and Drug ...

A strained, sore throat has been in the news – but did you know cannabis can help it? There is a buzz about sore throats today. While they are most common in colder months, spring allergies ...

Chlamydia symptoms typically depend on the parts of the body where the sexually transmitted infection (STI) occurs. You might experience anal or penile discharge if these organs are involved, or you ...

Credit: Visby Medical. The approval was based on a clinical study that included 2203 females aged 14 years and older. The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s ...

The FDA has granted Visby Medical authorization to market their at-home, over-the-counter diagnostic test that detects chlamydia, gonorrhea and trichomoniasis, according to a press release.

The at-home kit, according to the FDA, is the first of its kind to test for chlamydia, gonorrhea and trichomoniasis, three of the most common STIs with symptoms that often go unnoticed.

On a mission to combat the rising rates of chlamydia, Sanofi has received FDA fast-track designation for its mRNA vaccine candidate. This decision underscores the need for a preventative measure ...